Abbott Scores $16M Win In Suit Over Generic Tarka
A federal jury has awarded Abbott Laboratories $16 million in a suit against Glenmark Pharmaceuticals Ltd. over a generic version of Tarka, finding that the defendant infringed a patent covering the...To view the full article, register now.
Already a subscriber? Click here to view full article